Charles River Laboratories International (CRL) Operating Expenses (2016 - 2025)
Charles River Laboratories International has reported Operating Expenses over the past 17 years, most recently at $196.1 million for Q4 2025.
- Quarterly results put Operating Expenses at $196.1 million for Q4 2025, changed 0.22% from a year ago — trailing twelve months through Dec 2025 was $743.1 million (down 1.06% YoY), and the annual figure for FY2025 was $743.1 million, down 1.06%.
- Operating Expenses for Q4 2025 was $196.1 million at Charles River Laboratories International, up from $177.6 million in the prior quarter.
- Over the last five years, Operating Expenses for CRL hit a ceiling of $199.8 million in Q3 2023 and a floor of $131.7 million in Q2 2022.
- Median Operating Expenses over the past 5 years was $177.7 million (2025), compared with a mean of $176.3 million.
- Biggest five-year swings in Operating Expenses: fell 23.2% in 2022 and later soared 51.66% in 2023.
- Charles River Laboratories International's Operating Expenses stood at $144.1 million in 2021, then soared by 38.53% to $199.6 million in 2022, then fell by 1.25% to $197.1 million in 2023, then dropped by 0.73% to $195.7 million in 2024, then increased by 0.22% to $196.1 million in 2025.
- The last three reported values for Operating Expenses were $196.1 million (Q4 2025), $177.6 million (Q3 2025), and $191.5 million (Q2 2025) per Business Quant data.